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The layer II of the adult piriform cortex (PCX) contains a numerous population of
immature neurons. Interestingly, in both mice and rats, most, if not all, these cells
have an embryonic origin. Moreover, recent studies from our laboratory have shown
that they progressively mature into typical excitatory neurons of the PCX layer II.
Therefore, the adult PCX is considered a “non-canonical” neurogenic niche. These
immature neurons express the polysialylated form of the neural cell adhesion molecule
(PSA-NCAM), a molecule critical for different neurodevelopmental processes. Dopamine
(DA) is a relevant neurotransmitter in the adult CNS, which also plays important roles
in neural development and adult plasticity, including the regulation of PSA-NCAM
expression. In order to evaluate the hypothetical effects of pharmacological modulation
of dopaminergic neurotransmission on the differentiation of immature neurons of
the adult PCX, we studied dopamine D2 receptor (D2r) expression in this region
and the relationship between dopaminergic fibers and immature neurons (defined by
PSA-NCAM expression). In addition, we analyzed the density of immature neurons
after chronic treatments with an antagonist and an agonist of D2r: haloperidol and
PPHT, respectively. Many dopaminergic fibers were observed in close apposition to
PSA-NCAM-expressing neurons, which also coexpressed D2r. Chronic treatment with
haloperidol significantly increased the number of PSA-NCAM immunoreactive cells,
while PPHT treatment decreased it. These results indicate a prominent role of dopamine,
through D2r and PSA-NCAM, on the regulation of the final steps of development of
immature neurons in the adult PCX.
Keywords: piriform cortex, dopamine, dopamine D2 receptor, plasticity, PSA-NCAM
INTRODUCTION
In the last two decades, many studies have been conducted to characterize a population of immature
neurons, which is densely distributed in the layer II of the adult rodent piriform cortex (PCX).
Most, if not all, of these immature neurons are postmitotic cells generated during embryonic
development (Castillo-Gómez et al., 2008; Rubio et al., 2016), which progressively mature into
typical excitatory neurons of the PCX (Rotheneichner et al., 2018; Benedetti et al., 2019). These
immature neurons transiently express the polysialylated form of the neural cell adhesion molecule
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(PSA-NCAM) (Seki and Arai, 1991; Bonfanti et al., 1992), a
plasticity molecule involved in different neurodevelopmental
processes, such as neuronal migration, neurite extension, or
synaptogenesis (Rutishauser, 2008; Hildebrandt and Dityatev,
2013), which may also act as an insulating agent on these
cells, preventing or limiting the formation of synaptic contacts
(Gómez-Climent et al., 2008). PSA-NCAM-expressing cells in the
PCX of rodents can be divided into two morphological categories,
although intermediate forms are very common: (a) tangled (type
I) cells, which had a very small somata, lack axons, and have few
short dendrites with intricate trajectories and (b) complex (type
II) cells, which show typical dendritic branches and resemble
common excitatory neurons in the PCX layer II (see Bonfanti
and Nacher, 2012 for review). PSA-NCAM-expressing cells also
coexpress markers of immature neurons such as doublecortin or
TUC4 and lack or have very low expression of mature neuronal
markers, such as calcium calmodulin kinase IIα (CAMKII) or
NeuN (Gómez-Climent et al., 2008; Rubio et al., 2016). However,
these immature neurons express transcription factors exclusive
of excitatory neurons and lack those expressed by interneurons
(Gómez-Climent et al., 2008; Bonfanti and Nacher, 2012; Rubio
et al., 2016). The function of these immature neurons in the PCX
is still a mystery, but some studies have indicated that they are
affected by chronic stress and chronic corticosterone treatment
(Nacher et al., 2004), as well as by bulbectomy (Gómez-Climent
et al., 2011), which are considered animal models of major
depression (Planchez et al., 2019). Moreover, this population of
neurons is also affected by antidepressant treatment (Sairanen
et al., 2007). Together, these results suggest the involvement
of these neurons in the response to adverse experiences and
depressive-like behavior. This is also supported by recent work in
Dr. Vaidya’s laboratory, which demonstrated the contribution of
the monoamine norepinephrine, a neurotransmitter involved in
the response to stress and the therapeutics of major depression,
in the regulation of the number of PSA-NCAM-expressing cells
in the PCX of adult rats (Vadodaria et al., 2017). Interestingly,
previous studies from our laboratory have demonstrated that
PSA-NCAM levels in the cerebral cortex are regulated by
another monoamine, dopamine, acting through dopamine D2
receptor (D2r) (Castillo-Gómez et al., 2008, 2016), although
these studies were focused on the expression of PSA-NCAM
in prefrontocortical interneurons. The role of PSA-NCAM in
response to monoamines and, in general, to stress and other
aversive experiences in the adult brain must be related to its
capacity to induce plastic phenomena, such as synaptic and
dendritic remodeling, and also to its insulating properties,
which could limit transiently this plasticity (Nacher et al.,
2013). The monoamines influence the proliferation of neuronal
stem cells (NSCs) within the two neurogenic niches of the
adult brain: the subventricular zone (SVZ) and the subgranular
zone (SGZ) of the hippocampal dentate gyrus (Apple et al.,
2017). In particular, dopamine appears to control neurogenesis
in both SVZ and SGZ, as indicated by its experimental
manipulation (Höglinger et al., 2004). In a 6-OHDA rat model
of Parkinson’s disease, dopamine agonists induce a significant
increase in SVZ proliferation and seem to promote neuronal
differentiation in the olfactory bulb of 6-OHDA lesioned animals
(O’Keeffe et al., 2009; Winner et al., 2009). These actions of
dopamine are also evident during neurodevelopment, when
it plays important roles in the regulation of different stages
of neural development, including cell proliferation, migration,
and differentiation (Money and Stanwood, 2013). Cells in the
PCX receive inputs from dopaminergic neurons and express
dopamine receptors, especially D2 (Boyson et al., 1986). However,
the expression of these receptors specifically by the immature
neurons in layer II and the relationship between these cells and
dopaminergic terminals have not been explored yet. Therefore,
considering that dopamine plays a key role in the response to
stress and the etiopathology and treatment of major depression
(Belujon and Grace, 2015, 2017), and that it is a potent regulator
of neuronal development via its receptors (Todd, 1992; Schmidt
et al., 1996; Sung et al., 2006), it would be interesting to
investigate the influence of the pharmacological modulation of
dopaminergic neurotransmission on the population of immature
neurons in the PCX layer II. Consequently, to evaluate the
hypothetical effects of D2r antagonists and agonists on the
differentiation of immature neurons in the PCX layer II, we first
studied the expression of D2r on these cells and their relationship
with dopaminergic axons. Next, we explored whether the
experimental manipulation of dopaminergic signaling via D2r
antagonists and agonists may alter the rate of differentiation of
the immature neurons in the PCX by quantifying changes in the
density of PSA-NCAM-expressing cells in layer II.
MATERIALS AND METHODS
Animals
Twenty-four male Sprague–Dawley rats (3 months old,
300 ± 15 g, Harlan Iberica) were used in this study. Two rats
were used to study the expression of dopamine D2 receptors
(D2r) in PSA-NCAM immunoreactive cells and the spatial
relationship between these cells and fibers immunopositive for
tyrosine hydroxylase (TH) and the dopamine transporter (DAT).
Twenty-two rats were used for experimental manipulations of the
dopamine D2 receptors: 10 rats were used for the D2r antagonist
(haloperidol) experiment, and 12 rats were used for the D2r
agonist [2-(N-Phenethyl-N-propyl) amino-5-hydroxytetralin
hydrochloride (PPHT)] experiment. The animals were housed in
groups in a temperature and humidity-controlled environment
and were maintained on a 12-h light/dark cycle with free
access to food and water. Rats were allowed to habituate in our
facilities at least 1 week prior to the start of the experiments. All
animal experimentations were performed in accordance with
the Directive 2010/63/EU of the European Parliament and of the
Council of September 22, 2010 on the protection of animals used
for scientific purposes and was approved by the Committee on
Bioethics of the University of Valencia. Every effort was made to
minimize the number of animals used and their suffering.
Chronic Treatment With Haloperidol
Ten rats were divided randomly into two groups: control
(vehicle-treated; n = 5) and haloperidol treated (0.5 mg/kg/day,
n = 5). The injections were administered i.p. once daily for 26
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consecutive days (MacDonald et al., 2005; Castillo-Gómez et al.,
2008). Haloperidol (Sigma-Aldrich) was dissolved in 0.1 N acetic
acid, pH 5–6. Animals were perfused transcardially 24 h after the
final injection, and their brains were processed as described below
for PSA-NCAM immunohistochemistry.
Chronic Treatment With PPHT
Rats were randomly separated into two groups and administered
intraperitoneally with either the selective D2r agonist 2-(N-
Phenethyl-N-propyl) amino-5-hydroxytetralin hydrochloride
(PPHT, n = 6, 1.5 mg/kg/day in 0.9% NaCl; Sigma-Aldrich) or
saline (n = 6) once daily for 7 consecutive days (Sugahara and
Shiraishi, 1998; Castillo-Gómez et al., 2008, Castillo-Gómez et al.,
2011). The animals were sacrificed 24 h after the final injection.
Their brains were processed, and sections were analyzed using
immunohistochemistry for PSA-NCAM as described below.
Histology
All rats (n = 24) were perfused transcardially under deep
chloral hydrate anesthesia, first with saline and then with 4%
paraformaldehyde in sodium phosphate buffer 0.1 M, pH 7.4.
Thirty minutes after perfusion, the brains were extracted and
cryoprotected for 48 h with 30% sucrose in 0.1 M phosphate
buffer (PB). Coronal sections (50 µm) were obtained from
frozen brains (−30◦C) with a freezing–sliding microtome (Leica
SM2000R), collected in 10 subseries and stored at −20◦C in 30%
glycerol, 30% ethylene glycol in PB until used. One subseries
of sections was stained with toluidine blue and used to better
delimitate the boundaries of the PCX and its different layers.
Immunohistochemistry for Conventional
Light Microscopy
Tissue was processed “free-floating” for immunohistochemistry
as follows: Briefly, sections were incubated for 1 min in
an antigen-unmasking solution (0.01 M citrate buffer, pH
6) at 100◦C. After cooling down the sections to room
temperature, they were incubated with 10% methanol, 3%
H2O2 in phosphate-buffered saline (PBS) for 10 min to block
endogenous peroxidase activity. After this, sections were treated
for 1 h with 10% normal donkey serum (NDS) (Jackson
ImmunoResearch Laboratories, West Grove, PA, United States)
in PBS with 0.2% Triton-X100 (Sigma-Aldrich, St. Louis,
MO, United States) and were incubated overnight at room
temperature in monoclonal mouse IgM anti-polysialic acid-
NCAM antibody (1:1,400; MAB5324, Sigma-Aldrich). After
washing, sections were incubated for 2 h with donkey anti-mouse
IgM biotinylated antibody (1:250; Jackson ImmunoResearch
Laboratories), followed by an avidin–biotin–peroxidase complex
(ABC; Vector Laboratories, Peterborough, United Kingdom) for
1 h in PBS. Color development was achieved by incubating with
3,3′ diaminobenzidine tetrahydrochloride (DAB; Sigma-Aldrich)
and H2O2 for 4 min. PBS containing 0.2% Triton-X100 and 5%
NDS was used for primary and secondary antibodies dilution.
All sections passed through all procedures simultaneously in
order to minimize any difference from immunohistochemical
staining itself.
The anti-PSA-NCAM antibody was generated against
rat embryonic spinal cord membranes. The specificity of
immunostaining in our tissue was tested in four different ways,
as described before (Gómez-Climent et al., 2008): (a) three
different anti-PSA antibodies were used, and they rendered
exactly the same pattern of immunostaining, (b) pretreatment
of the antibody with a-2,8-linked sialic polymer (colominic acid,
Sigma) overnight, or the primary antibody omission during the
immunohistochemistry prevented all the labeling in the piriform
cortex layer II, (c) PSA immunohistochemistry of sections
from animals injected intracerebrally with EndoN resulted in a
complete absence of PSA immunostaining in the area affected
by the injection, and (d) immunostaining was absent from adult
CNS tissue of St8SiaII/St8SiaIV double knockout mice.
Immunohistochemistry for Confocal
Microscopy
In general, sections were processed as described above but
omitting the endogenous peroxidase block. The first day, all
sections were incubated overnight at room temperature with
the following primary antibody cocktails: (a) monoclonal mouse
IgM anti-PSA-NCAM (1:1,400; MAB5324, Sigma-Aldrich) and
polyclonal rabbit anti-human dopamine receptor (D2r) (1:200;
AB5084P, Sigma-Aldrich) or (b) monoclonal mouse IgM Anti-
PSA-NCAM, monoclonal rat IgG anti-dopamine transporter
(DAT) (1:200; MAB369, Sigma-Aldrich), and monoclonal mouse
IgG1 anti-tyrosine hydroxylase (TH) (1:200; MAB318, Sigma-
Aldrich). Forty-eight hours later, sections were washed and
incubated for 2 h with the following cocktail of fluorescent
secondary antibodies: goat anti-mouse IgM conjugated with
Alexa 555 (1:200; Molecular Probes, Eugene, OR, United States),
donkey anti-rabbit IgG conjugated with Alexa 488 (1:200;
Invitrogen), goat anti-rat IgG (cross-adsorbed) conjugated with
Alexa 488 (1:200; Molecular Probes, Eugene, OR, United States)
and goat anti mouse IgG1 conjugated with Alexa 647 (1:200;
Life Technologies). All sections were mounted on slides
and coverslipped using DakoCytomation fluorescent mounting
medium (Dako). The omission of the primary antibodies during
the immunohistochemical protocols resulted in total absence
of immunostaining.
The D2r antibody was raised against a 28-amino acid fragment
(284–311) within the cytoplasmic third loop (aa 284–311) of
human dopamine D2r (Hersch et al., 1995). The immunogen
peptide has no significant homology with other subtypes of
dopamine receptors (D1, D3–D5), and the antiserum recognizes
both short and long forms of D2r (Boundy et al., 1993). The
specificity of the antiserum for the immunogen peptide was
shown in rats by the absence of immunoreactivity in controls
of preimmune antiserum and immunogen peptide adsorption
(Boundy et al., 1993).
The dopamine transporter (DAT) antibody used in our
study corresponds to the DAT/Nt antibody generated against
human DAT N-terminus amino acids 1–66. The specificity
of this antibody has been demonstrated by immunoblot
analysis, immunoprecipitation, preadsorption followed by
immunoblotting and immunohistochemistry, and several
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immunohistochemical assays, and it has been validated for
the detection of dopamine transporter in rats (Wersinger
et al., 2004; Bianco et al., 2008; García-Cabezas et al., 2009;
Pandolfo et al., 2013).
The mouse monoclonal anti-tyrosine hydroxylase
antibody was raised against purified TH from the PC
12 pheochromocytoma cell line; this antibody recognizes
recombinant TH by Western blot analysis (Wolf and
Kapatos, 1989). The anti-TH antibody labels a single
protein band in the molecular weight range of 56–60 kDA
on Western blots prepared from VTA protein homogenates
(Shepard et al., 2006). In addition, this anti-TH antibody
was used to demonstrate that midbrain unilateral lesion
with 6-hydroxydopamine (6-OHDA) results in lack of
TH immunolabeling in the lesioned site, whereas it is
preserved in the contralateral unlesioned midrain (Sarabi
et al., 2001). The clone LNC1 has been validated for use in
immunohistochemistry with more than 700 product citations
(manufacturer’s information).
Confocal Analysis and Quantification
The sections were observed under a confocal microscope
(Leica TCS-SPE). Z-series of optical sections (0.5 µm apart)
of the whole thickness of the histological sections were
obtained using sequential scanning mode. These stacks were
processed with FIJI/ImageJ software (Schindelin et al., 2012).
Fifty PSA-NCAM immunoreactive cells were randomly selected
from all the sections containing PCX (10 sections between
Bregma -1.40 to -3.80 mm (Herman and Watson, 1987)
to analyze their spatial relationship with TH and DAT
immunoreactive fibers. To obtain the percentages describing
their colocalization with D2r, the quantification was performed
blindly by first evaluating PSA-NCAM neurons in individual
detection channels to assess the distribution of D2r population,
followed by merging the single images to identify and
count doubly labeled neurons. In addition, 25 TH fibers
were also selected from the same sections to analyze their
colocalization with DAT.
Quantification of the Density of
PSA-NCAM Expressing Cells
In order to study the density of PSA-NCAM-expressing cells
in the PCX layer II (haloperidol and PPHT experiments), two
sections per animal were selected from the following coordinates:
bregma -1.40 mm and bregma -3.60 mm (Herman and Watson,
1987). Cell counting was performed manually, using an Olympus
CX41 microscope, and results were expressed as density of
immunopositive cells per mm2.
Statistical Analyses
After checking the normality and homoscedasticity of the
data, we used unpaired Student’s t-tests to compare control
and experimental groups. Analysis was performed using
the statistical package SPSS v22.0 (IBM). In every test,





Dopaminergic Fibers in the Rat Piriform
Cortex Layer II
We analyzed whether TH immunoreactive fibers were closely
apposed to PSA-NCAM immunoreactive neurons in the rat
PCX layer II, using double immunostaining with antibodies
against these two markers. Fibers containing TH were sparse
in the three-layered PCX, but many of them were observed in
close apposition to PSA-NCAM-expressing neurons in layer II
(Figures 1A,A1– 3). Since TH can also be found in noradrenergic
axons, we analyzed the coexpression of TH and DAT in
fibers closely apposed to PSA-NCAM immunoreactive neurons,
confirming their dopaminergic phenotype (Figures 1B,B1–3).
Dopamine D2 Receptor Expression in
PSA-NCAM Immunoreactive Neurons
Using double immunohistochemistry for PSA-NCAM and D2r,
we also analyzed whether PSA-NCAM immunoreactive neurons
in the rat PCX layer II coexpressed this receptor. Interestingly,
we found that 55% of these cells coexpressed D2r. The detailed
analysis of its expression showed that D2r immunoreactivity was
predominantly localized in the periphery of the somata, in the
same compartment where PSA-NCAM immunoreactivity can be
found (Figures 1C1–3).
Effects of Chronic Treatments With
D2 Receptor Antagonists and Agonists
We next examined whether the pharmacological modulation
of dopaminergic neurotransmission, using D2r antagonists and
agonists, influenced the density of immature neurons expressing
PSA-NCAM within the rat PCX layer II.
Density of PSA-NCAM Immunoreactive Cells After
Chronic Haloperidol Treatment
Twenty-six days of chronic haloperidol treatment induced an
increase in the density of PSA-NCAM-expressing cells in the
rat PCX layer II (Figures 2A,B). This increase was statistically
significant (p = 0.028) (Figure 2E).
Density of PSA-NCAM Immunoreactive Cells After
Chronic PPHT Treatment
Seven days of chronic PPHT treatment produced a decrease in
the density of PSA-NCAM-expressing cells in the rat PCX layer
II (Figures 2C,D). This reduction was statistically significant
(p = 0.015) (Figure 2F).
DISCUSSION
The present study describes the relationship of dopaminergic
neurotransmission with the population of immature neurons
in the PCX layer II of adult rats. We have identified this
population of cells by the expression of PSA-NCAM, a
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FIGURE 1 | Confocal microscopic analysis of PSA-NCAM immunoreactive neurons and dopaminergic fibers in the piriform cortex layer II. (A) Double PSA-NCAM/TH
immunohistochemistry. Note the TH immunoreactive fibers surrounding and contacting PSA-NCAM-expressing cells. In (A1–A3), a detailed view of the magnification
of the squared area in (A) can be observed. (B) Double DAT/TH immunohistochemistry. Observe the expression of DAT on TH fibers, squared area in (B), and
arrowheads in (B1–B3) images. (C1) Neuron expressing PSA-NCAM in the piriform cortex layer II. In (C1–C3) note the presence of D2r expression on
PSA-NCAM-expressing cells. All the images in this figure are 2D projections of 25 consecutive confocal planes located 0.5 µm apart. Scale bars: 50 µm for (A);
30 µm for (B); 10 µm for (C), and 15 µm for (A1–A3,B1–B3). PSA-NCAM, polysialylated form of the neural cell adhesion molecule; TH, tyrosine hydroxylase; DAT,
dopamine transporter; D2r, dopamine D2 receptor.
plasticity-related molecule, which is strongly expressed in
their somata and dendrites (Seki and Arai, 1991; Bonfanti,
2006). The distribution and morphology of these cells are
identical to those described previously by us and others
in rats (Bonfanti et al., 1992; Nacher et al., 2002). Most of
the immature neurons in the adult rat PCX layer II have
been generated during embryonic development (Gómez-
Climent et al., 2008) and progressively mature into functional
excitatory neurons in this layer (Rotheneichner et al., 2018;
Benedetti et al., 2019), although the factors triggering or
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FIGURE 2 | PSA-NCAM-expressing cells in the rat piriform cortex. Microphotographs showing PSA-NCAM immunostaining in control (A,C) and after chronic
treatment with haloperidol (B) and PPHT (D). (A1–D1) are higher magnifications of the squared areas in (A–D). (E,F) Graphs showing changes in the density of
PSA-NCAM-expressing cells in the piriform cortex layer II. Asterisks indicate statistically significant differences from the control group after unpaired Student’s t-test;
p < 0.05 (*). Scale bars: 200 µm for (A–D); 100 µm for (A1–D1). PSA-NCAM, polysialylated form of the neural cell adhesion molecule; PPHT,
2-(N-phenethyl-N-propyl) amino-5-hydroxytetralin hydrochloride.
modulating these final steps of differentiation are still far from
being understood.
We have decided to study the influence of the pharmacological
modulation of dopaminergic neurotransmission on this
immature neuronal population following three lines of
evidence: (1) this monoamine regulates the expression of
PSA-NCAM in the adult cerebral cortex (Castillo-Gómez et al.,
2008), (2) another monoamine, norepinephrine, affects this
immature neuronal population (Vadodaria et al., 2017), and (3)
dopamine regulates neuronal differentiation during development
(Money and Stanwood, 2013).
We have described the presence of fibers expressing TH/DAT
in the close vicinity of PSA-NCAM-expressing somata. In
accordance with previous studies in the PCX (Plantjé et al.,
1987; Datiche and Cattarelli, 1996), we have observed that
several immunoreactive fibers coexpressing TH and DAT, and
consequently dopaminergic, could be found apposed to PSA-
NCAM-expressing somata. It is unlikely, however, that these
fibers establish synapses with the immature neurons because
the presence of PSA-NCAM on their membranes prevents
this type of contacts. There is evidence that only the cells
in the most advanced stages of maturation show dendritic
spines, in which some scarce synaptic contacts can be found
(Gómez-Climent et al., 2008). However, monoamines, including
dopamine, act in great part by volume transmission (Vizi et al.,
2010), a type of paracrine signaling and, thus, could exert their
effect if receptors were present in the target neurons. In any
case, further analyses using electron microscopy combined with
immunohistochemistry would be necessary to unequivocally
describe the relationship between dopaminergic fibers and the
immature neurons.
Since previous experiments in our laboratory have
demonstrated that the expression of PSA-NCAM in the
prefrontal cortex can be modulated by dopamine through the
pharmacological manipulation of D2r (Castillo-Gómez et al.,
2008), we have studied their expression in the immature neurons
in the PCX and confirmed their presence. This is consistent with
previous data describing the expression of D2r in this cortical
region (Meador-Woodruff et al., 1989). Although the cellular
pattern of D2r expression in the PCX has not been explored
yet, there is evidence of the presence of these receptors in both
inhibitory and excitatory neurons in other cortical regions
(Santana et al., 2009). Consequently, some of the D2r-expressing
cells in the PCX may be the immature neurons in layer II,
which display an excitatory phenotype and differentiate into
typical excitatory neurons of this region (Gómez-Climent
et al., 2008; Rubio et al., 2016; Rotheneichner et al., 2018). It is
important to note that we have only detected D2r in half of the
PSA-NCAM-positive cells, which raises questions on whether
the expression of these receptors is restricted to certain phases of
the development of these neurons. Since the presence of D1r has
also been described in the PCX and in cortical excitatory cells,
future studies should also study their putative expression in the
immature neurons of the PCX and the influence of their specific
manipulation on these cells.
Our study also shows that the pharmacological manipulation
of D2r with specific antagonists and agonists produces opposite
effects on the population of immature neurons in the PCX.
Frontiers in Neuroscience | www.frontiersin.org 6 October 2020 | Volume 14 | Article 574234
fnins-14-574234 October 3, 2020 Time: 17:46 # 7
Coviello et al. Dopamine and Adult Immature Neurons
We think that the decrease in the number of cells expressing
PSA-NCAM induced by the D2r agonist PPHT may represent
an increase in the rate of differentiation of these cells, which
progressively lose PSA-NCAM expression as they reach their
maturity (Rotheneichner et al., 2018). In fact, PSA-NCAM
appears to have an insulating role in this immature neuronal
population, limiting the formation of synaptic contacts (Gomez-
Climent et al., 2011). On the contrary, the increase in the
number of PSA-NCAM-positive cells observed after treatment
with haloperidol (a D2r antagonist) may be the consequence of
a decrease in the rate of differentiation of these neurons. The
number of immature neurons in the PCX decreases continuously
as life progresses (Varea et al., 2009; Rotheneichner et al., 2018).
Consequently, if the differentiation is slowed by haloperidol,
at the end of the treatment, we will detect more PSA-NCAM-
expressing cells in the animals receiving this drug than in the
controls, in which a larger cell population will have reached the
PSA-NCAM-negative mature stage. However, further analyses
with markers of mature neurons, such as NeuN or CAMKII,
and the use of transgenic animals similar to those used in
the Rotheneichner et al. (2018) study should be performed
to demonstrate clearly this hypothesis. The effects of the
pharmacological manipulation of D2r on PSA-NCAM expression
have been already studied in the adult medial prefrontal cortex
(mPFC) (Castillo-Gómez et al., 2008, Castillo-Gómez et al.,
2011). However, the effects of these manipulations produce
opposite effects to those detected in the PCX layer II. It has to
be noted, however, that in the mPFC, PSA-NCAM is exclusively
expressed by mature inhibitory neurons (Varea et al., 2005)
and that the role of this molecule in these interneurons may
be different than in the PCX immature neurons. In fact, the
regulation of PSA-NCAM expression should also be different
because the polysialyltransferase St8SiaII is responsible for the
addition of PSA to NCAM in the immature neurons of the PCX,
while St8SiaIV plays this role in mature interneurons (Nacher
et al., 2010). Ongoing studies in our laboratory are exploring the
effects of PSA depletion on the maturation of PCX layer II cells.
Our results on the impact of the pharmacological modulation
of D2r are particularly interesting because there are different
lines of evidence suggesting the involvement of the immature
neurons in the adult cortical layer II in psychiatric disorders
and their treatment, especially in major depression. Although
in rodents this cell population is restricted mainly to the
PCX, they have a wider distribution in gyrencephalic animals
(Varea et al., 2011; Piumatti et al., 2017), including humans
(Ní Dhúill et al., 1999; Cai et al., 2009), covering most
neocortical regions. Interestingly, similar cells have also been
found in the human amygdala, a region critically involved in
mood disorders (Martí-Mengual et al., 2013; Sorrells et al.,
2019). Previous reports from our laboratory have shown
that two animal models of major depression, chronic stress,
and chronic corticosterone treatment have a dramatic impact
on the number of these immature neurons (Nacher et al.,
2004). Olfactory bulbectomy, another accepted model of major
depression, induces the differentiation of these cells (Gómez-
Climent et al., 2011). Moreover, chronic treatment with the
antidepressant imipramine increases PSA-NCAM expression in
the PCX layer II of adult rats (Sairanen et al., 2007). These
results are also interesting because imipramine, besides its
action as a 5HT and norepinephrine reuptake inhibitor, also
blocks D2 receptors (Smiałowski, 1991). This is consistent with
the effects that we observe with haloperidol in the present
study. In addition, chronic treatment with the antidepressant
fluoxetine, a 5HT reuptake blocker, also induces an increase
in PSA-NCAM expression in the rat entorhinal cortex layer II,
a region where some PSA-NCAM + immature neurons can
also be detected (Varea et al., 2007). Finally, the modulation
of α2-Adrenergic receptors, which are also involved in the
pathogenesis of major depression and its treatment, also
impacts the population of immature neurons in the PCX
layer II (Vadodaria et al., 2017). Taking into account all these
results, there is enough evidence to promote the study of the
immature neurons in the layer II of the cerebral cortex of
humans, specially comparing major depression patients with
healthy controls.
In conclusion, our results strongly indicate a prominent role of
D2r and PSA-NCAM, on the differentiation of immature neurons
in the adult PCX, although further analyses closely following
the final development of these cells should be necessary to
understand this mechanism. Interestingly, together with previous
evidence, our data also suggest that this neuronal cell population
is the target of drugs affecting the monoaminergic systems and
its involvement in the etiopathology of psychiatric disorders in
which these systems are altered.
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